AHA Names Top CVD Advances for 2023

Advances in stroke, a novel antihypertensive, and new evidence that diabetes drugs may offer CVD benefits for those without diabetes are among the top developments in 2023, on the AHA's annual list.
Medscape Medical News

source https://www.medscape.com/viewarticle/aha-names-top-cvd-advances-2023-2023a1000wtt?src=rss